Jushi Holdings Inc. (OTCMKTS:JUSHF - Free Report) - Analysts at Atb Cap Markets issued their Q4 2025 earnings per share (EPS) estimates for Jushi in a research note issued to investors on Sunday, March 9th. Atb Cap Markets analyst F. Gomes expects that the company will post earnings of ($0.05) per share for the quarter. Atb Cap Markets currently has a "Strong Sell" rating on the stock. The consensus estimate for Jushi's current full-year earnings is ($0.23) per share. Atb Cap Markets also issued estimates for Jushi's FY2029 earnings at ($0.09) EPS.
Jushi Trading Down 8.0 %
Shares of Jushi stock opened at $0.27 on Tuesday. The company has a market capitalization of $53.09 million, a P/E ratio of -1.00 and a beta of -0.83. The stock has a fifty day simple moving average of $0.33 and a 200 day simple moving average of $0.40. Jushi has a 12-month low of $0.22 and a 12-month high of $0.92.
Jushi (OTCMKTS:JUSHF - Get Free Report) last released its quarterly earnings results on Wednesday, March 12th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.02). The business had revenue of $65.86 million during the quarter, compared to analyst estimates of $64.03 million.
Jushi Company Profile
(
Get Free Report)
Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Jushi, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.
While Jushi currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
